Detalhe da pesquisa
1.
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
N Engl J Med
; 387(25): 2331-2343, 2022 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546625
2.
The safety and tolerability of linezolid in novel short-course regimens containing bedaquiline, pretomanid and linezolid to treat rifampicin-resistant tuberculosis: an individual patient data meta-analysis.
Clin Infect Dis
; 2023 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37874021
3.
Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL.
Clin Infect Dis
; 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38419566
4.
Multidrug-resistant tuberculosis.
Lancet
; 394(10195): 298-299, 2019 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31354136
5.
Principles for designing future regimens for multidrug-resistant tuberculosis.
Bull World Health Organ
; 92(1): 68-74, 2014 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24391302
6.
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial.
Lancet Respir Med
; 12(2): 117-128, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37980911
7.
Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis.
PLOS Glob Public Health
; 2(12): e0001337, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36962909
8.
TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis.
Trials
; 23(1): 484, 2022 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35698158
9.
Capturing patient-reported and quality of life outcomes with use of shorter regimens for drug-resistant tuberculosis: mixed-methods substudy protocol, TB PRACTECAL-PRO.
BMJ Open
; 11(9): e043954, 2021 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34489263
10.
Population pharmacokinetics and pharmacodynamics of investigational regimens' drugs in the TB-PRACTECAL clinical trial (the PRACTECAL-PKPD study): a prospective nested study protocol in a randomised controlled trial.
BMJ Open
; 11(9): e047185, 2021 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34489274
11.
Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan.
Trials
; 22(1): 881, 2021 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34863253
12.
Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan.
ERJ Open Res
; 7(1)2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33585652
13.
Cost-effectiveness of new MDR-TB regimens: study protocol for the TB-PRACTECAL economic evaluation substudy.
BMJ Open
; 10(10): e036599, 2020 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33039989
14.
Resistance to second-line drugs in multidrug-resistant tuberculosis.
Lancet
; 381(9867): 625, 2013 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23439097
15.
The 1/4/6x24 campaign to cure tuberculosis quickly.
Nat Med
; 29(1): 16-17, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36627438
16.
Counting children: comparing reporting for paediatric HIV and tuberculosis.
Bull World Health Organ
; 89(12): 855, 2011 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22271937
17.
Association of BMI category change with TB treatment mortality in HIV-positive smear-negative and extrapulmonary TB patients in Myanmar and Zimbabwe.
PLoS One
; 7(4): e35948, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22545150
18.
Principles for designing future regimens for multidrug-resistant tuberculosis
Bull. W.H.O. (Print)
; 92(1): 68-74, 2014-1-01.
Artigo
em Inglês
| WHOLIS | ID: who-271445
19.
Counting children: comparing reporting for paediatric HIV and tuberculosis
Bull. W.H.O. (Print)
; 89(12): 855-855, 2011-12-01.
Artigo
em Inglês
| WHOLIS | ID: who-271052